Stratec Biomedical: Excellent Strategic Fit With Integrated Consumables
Edison | Jun 15, 2016 09:07AM ET
STRATEC Biomedical AG (DE:SBSG), a designer and builder of automated OEM diagnostic systems, has announced its intention to acquire an Austrian business that designs and manufactures complex precision consumables for high-end biomedical and diagnostic systems. This is an excellent strategic fit as it will allow Stratec to integrate high-value consumables into system designs and accumulate recurring revenues: Stratec expects a 20% CAGR to 2020 on DADC 2015 sales of €17m. Stratec is experiencing reduced Chinese orders and the guided 5% EBIT of DADC may lower the 2017 EBIT margin to 17%.
Consumables fit into Stratec’s system solutions
Consumables are often taken for granted and seen as low value. In reality, for the advanced new systems now in use, they are an integral part of the test and crucial to accuracy. For example, if liquid biopsy for cancer becomes mainstream, users will need millions of high-precision consumables costing €30-100 each. As yet DADC BioSciences, a Sony subsidiary, is waiting for developed systems, like the Stratec-produced Simoa from Quanterix, to build sales and use rates. Once this happens, Stratec should see major benefits but timing is uncertain. DADC sales are now annualised at €17m with about 5% EBIT margin according to Stratec. This makes the €30m cash acquisition price 1.8x sales and about 25x EBIT (exact figures are not disclosed). This appears a good price for an acquisition with major opportunities and excellent strategic fit. Short term it will limit the EBIT margin.
To read the entire report Please click on the pdf File Below
Stratec Biomedical - Excellent Strategic Fit With Integrated Consuma
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.